Fidelity Investments’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.66M | Buy |
|
|||||
|
2025
Q2 | $1.08M | Buy |
|
|||||
|
2025
Q1 | $794K | Buy |
|
|||||
|
2024
Q4 | $1.35M | Buy |
|
|||||
|
2024
Q3 | $1.08M | Buy |
|
|||||
|
2024
Q2 | $782K | Buy |
|
|||||
|
2024
Q1 | $29.4K | Buy |
|
|||||
|
2023
Q4 | $27K | Sell |
|
|||||
|
2023
Q3 | $433K | Buy |
|
|||||
|
2023
Q2 | $508K | Buy |
|
|||||
|
2023
Q1 | $398K | Sell |
|
|||||
|
2022
Q4 | $470K | Buy |
|
|||||
|
2022
Q3 | $656K | Sell |
|
|||||
|
2022
Q2 | $977K | Sell |
|
|||||
|
2022
Q1 | $1.29M | Sell |
|
|||||
|
2021
Q4 | $32.5M | Buy |
|
|||||
|
2021
Q3 | $33.9M | Sell |
|
|||||
|
2021
Q2 | $43.2M | Buy |
|
|||||
|
2021
Q1 | $23.7M | Sell |
|
|||||
|
2020
Q4 | $39.7M | Buy |
|
|||||
|
2020
Q3 | $45.3M | Buy |
|
|||||
|
2020
Q2 | $16M | Buy |
|
|||||
|
2020
Q1 | $3K | Sell |
|
|||||
|
2019
Q4 | $15.7M | Buy |
|
|||||
|
2019
Q3 | $6.94M | Sell |
|
|||||
|
2019
Q2 | $17.6M | Sell |
|
|||||
|
2019
Q1 | $25.9M | Sell |
|
|||||
|
2018
Q4 | $30.7M | Buy |
|
|||||
|
2018
Q3 | $27.6M | Buy |
|
|||||
|
2018
Q2 | $14.7M | Buy |
|
|||||
|
2018
Q1 | $5.23M | Sell |
|
|||||
|
2017
Q4 | $5.75M | Sell |
|
|||||
|
2017
Q3 | $6.49M | Sell |
|
|||||
|
2017
Q2 | $7.42M | Sell |
|
|||||
|
2017
Q1 | $8.39M | Buy |
|
|||||
|
2016
Q4 | $9.47M | Buy |
|
|||||
|
2016
Q3 | $6.51M | Sell |
|
|||||
|
2016
Q2 | $14.2M | Sell |
|
|||||
|
2016
Q1 | $19.7M | Sell |
|
|||||
|
2015
Q4 | $21.9M | Sell |
|
|||||
|
2015
Q3 | $15.7M | Buy |
|
|||||
|
2015
Q2 | $18.1M | Buy |
|
|||||
|
2015
Q1 | $15.7M | Buy |
|
|||||
|
2014
Q4 | $14.7M | Sell |
|
|||||
|
2014
Q3 | $12.2M | Sell |
|
|||||
|
2014
Q2 | $13.1M | Sell |
|
|||||
|
2014
Q1 | $15.2M | Buy |
|
|||||
|
2013
Q4 | $9.85M | Buy |
|
|||||
|
2013
Q3 | $6.63M | Sell |
|
|||||
|
2013
Q2 | $5.63M | Buy |
|